Faron Pharmaceuticals Oy (AIM: FARN)
Health Care · Biotechnology · FI
£0.37
+5.19% today · -79.1% 1Y
Faron Pharmaceuticals Oy (AIM: FARN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $99.74M.
Over the last twelve months the share price has lost 79.1%, trading between 0.34 and 2.10.
Tweenvest scores Faron Pharmaceuticals Oy across four factors: quality 24/100, value 30/100. Its strongest factor is value.
FARN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $99.74M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 1.11
- 52-week high
- £2.10
- 52-week low
- £0.34
- Avg volume (3M)
- —
- Shares outstanding
- 206.54M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anixa Biosciences, Inc.NasdaqCM: ANIX | $102.55M | $2.91 | -1.36% |
| TiumBio Co., Ltd.KOSDAQ: A321550 | $100.93M | ₩4,525.00 | +1.91% |
| Citius Oncology, Inc.NasdaqCM: CTOR | $100.47M | $0.84 | -12.11% |
| Cellectis S.A.ENXTPA: ALCLS | $99.91M | €1.23 | -2.07% |
| Pet Pharm Biotech Co., Ltd.TPEX: 7762 | $99.39M | NT$54.50 | +2.44% |
| SynAct Pharma ABOM: SYNACT | $99.32M | Skr16.90 | -5.06% |
| Novogenia AGMUN: 7V0 | $98.11M | €7.20 | — |
| Y-Biologics, Inc.KOSDAQ: A338840 | $97.21M | ₩8,520.00 | +2.16% |
Figures last refreshed Oct 4, 2026.